The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion Unapproved Peptides Lack Safety Data, Regulatory Incentives Misaligned Matt Kaeberlein posted on the topic LinkedIn FDA to weigh easing limits on unproven peptides promoted by RFK Jr. Is BPC 157 Banned? Oral vs. Injectable Forms Explained FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News